Inflammation-related miR-155-5p as an <i>APOE</i> ε4-modulated biomarker for amyloid pathology in mild cognitive impairment
ε4, is associated with AD-relevant pathological features and may provide complementary information at the MCI stage, with potential utility in monitoring biological responses to anti-Aβ therapy.
Authors
- Akira Hashiramoto (ORCID: https://orcid.org/0000-0003-2166-4511)
- Kazuki Takano
- Hisatomo Kowa (ORCID: https://orcid.org/0000-0002-5300-8589)
- Jun Fujita
- Kohsuke Yoshida (ORCID: https://orcid.org/0000-0002-8728-5226)
- Tetsuo Kashibayashi (ORCID: https://orcid.org/0000-0002-0046-4628)
- Nonoka Saito
- Shunsaburo Ando
- Ryuichi Takahashi
Institutions
- Hyogo University of Health Sciences (JP)
- Hyogo Social Welfare Corporation (JP)
- Kobe University (JP)
Publication Details
- Journal
- Journal of Alzheimer s Disease
- Published
- 2026-04-03
- DOI
- https://doi.org/10.1177/13872877261437135
- Primary Topic
- Neuroinflammation and Neurodegeneration Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Hyogo Science and Technology Association
- Foundation of Kinoshita Memorial Enterprise
- Japan Society for the Promotion of Science